ARCHIVES

Guidelines Adopted For Pathology Review

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

NCI Toughens Criteria for MERIT Awards

February 23, 1996

Tumor Size Predicts Survival In Early-Stage Lung Cancer

November 28, 2003

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014